Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes最新文献

筛选
英文 中文
Establishment 5 doses presentation of the triple viral vaccine without albumin to reduce loss during administration 建立5剂不含白蛋白的三联病毒疫苗,以减少给药过程中的损失
S. Assumpção, M. Freire, E. Caride, C. Crespo
{"title":"Establishment 5 doses presentation of the triple viral vaccine without albumin to reduce loss during administration","authors":"S. Assumpção, M. Freire, E. Caride, C. Crespo","doi":"10.35259/isi.2022_52264","DOIUrl":"https://doi.org/10.35259/isi.2022_52264","url":null,"abstract":"the established approval limits. Conclusion: The results demonstrate that only the 5-dose presentation, with a 67% reduction in filling volume, replacement of the current vial model and recalculation of vaccine component concentrations, maintains the productive capacity with the number of doses per batch produced, in the same time and lyophilization cycle currently used.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73327851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generation and characterization of anti-CD19 CAR-T cells overexpressing the protein PHF19 过表达PHF19蛋白的抗cd19 CAR-T细胞的产生和表征
K. Hajdu, Leonardo Silva, M. Bonamino
{"title":"Generation and characterization of anti-CD19 CAR-T cells overexpressing the protein PHF19","authors":"K. Hajdu, Leonardo Silva, M. Bonamino","doi":"10.35259/isi.2022_52280","DOIUrl":"https://doi.org/10.35259/isi.2022_52280","url":null,"abstract":"","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74592438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing usage of remaining blood from Interferon Gamma Releasing Assay (IGRA) to search for immune signatures and biomarkers for Latent Tuberculosis Infection (LTBI) 优化干扰素γ释放试验(IGRA)剩余血液的使用,寻找潜伏性结核感染(LTBI)的免疫特征和生物标志物
B. Ferreira, M. Nunes, D. Rodrigues, P. Rigato
{"title":"Optimizing usage of remaining blood from Interferon Gamma Releasing Assay (IGRA) to search for immune signatures and biomarkers for Latent Tuberculosis Infection (LTBI)","authors":"B. Ferreira, M. Nunes, D. Rodrigues, P. Rigato","doi":"10.35259/isi.2022_52179","DOIUrl":"https://doi.org/10.35259/isi.2022_52179","url":null,"abstract":"of T cell activation molecules IFN-g production in response to QTF We immunophenotyped the remaining blood cells used in the QTF test. Our preliminary results show that, as expected, most of the cells present in the lymphocyte gate are CD45+/CD3+ with a median of 77.8% (Tube N, Nill); 82.5% (Mitogen, M); 74.03% (TB1) and 76.75% (TB2). Considering CD4+ T cells, we detected 56% (N), 44% (M), 56% (TB1) and 55% (TB2). On the other hand, we showed that there were 28% (N), 25% (M), 31% (TB1) and 29% (TB2) of CD8+ T cells in the tubes. When we looked for activation markers (CD69, CD71 and HLA-DR) we showed that when T cells are stimulated with mitogen there are higher percentages of T cells, TCD4+ TCD8+ expressing these markers. For the antigen-specific tubes (TB1 and TB2) there were not enough QTF positive samples to conclude the correlation of IFN-g production with the expression of these activation markers. Conclusion: We conclude that it is possible to better characterize the immune phenotype of remaining blood from IGRA.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83297598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continued Process Verification for COVID-19 Vaccine Formulation and Packaging (recombinant) COVID-19疫苗制剂和包装(重组)继续工艺验证
Paulo Silva, Pedro Correia, Daiane Grugel, Victor Ferreira, Rayane Gonçalves
{"title":"Continued Process Verification for COVID-19 Vaccine Formulation and Packaging (recombinant)","authors":"Paulo Silva, Pedro Correia, Daiane Grugel, Victor Ferreira, Rayane Gonçalves","doi":"10.35259/isi.2022_52269","DOIUrl":"https://doi.org/10.35259/isi.2022_52269","url":null,"abstract":"period of less than 1 year of production, as 391 batches were produced. All variables evaluated are under control or on alert. As this is a new product, it is understood that some variations may be inherent to the process and therefore, all will continue to be evaluated on a quarterly basis until completing the period of one more year for the evaluation of phase 3b of the CPV.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"70 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81774036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technological roadmap in covid-19 vaccine production covid-19疫苗生产技术路线图
Silvia Santos, Wanise Barroso
{"title":"Technological roadmap in covid-19 vaccine production","authors":"Silvia Santos, Wanise Barroso","doi":"10.35259/isi.2022_52278","DOIUrl":"https://doi.org/10.35259/isi.2022_52278","url":null,"abstract":"","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82330482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scale up of molecular kit for diagnostic of COVID-19 during pandemic period 在大流行期间扩大用于诊断COVID-19的分子试剂盒规模
Carla Almeida, M. Stávale, Fernanda Santos, Patricia Baptista
{"title":"Scale up of molecular kit for diagnostic of COVID-19 during pandemic period","authors":"Carla Almeida, M. Stávale, Fernanda Santos, Patricia Baptista","doi":"10.35259/isi.2022_52178","DOIUrl":"https://doi.org/10.35259/isi.2022_52178","url":null,"abstract":"","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85813280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A significant portion of undergraduate health science students are not immunized as they should 相当一部分健康科学本科学生没有接种他们应该接种的疫苗
C. Vitral, Samuel Machado, Camila Santos, E. Pinto, Leonardo Abreu
{"title":"A significant portion of undergraduate health science students are not immunized as they should","authors":"C. Vitral, Samuel Machado, Camila Santos, E. Pinto, Leonardo Abreu","doi":"10.35259/isi.2022_52217","DOIUrl":"https://doi.org/10.35259/isi.2022_52217","url":null,"abstract":"measles, varicella meningococcal 63.8% indicated by SUS. Conclusion: The study showed an overall low vaccination coverage among health science students along with a poor perception about vaccination schedules. These results are worrisome, considering that these future HCWs will guide the population in the use of vaccines. To overcome this, the study of vaccines and related diseases should be envisaged and deepened as part of the health science courses curricula.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89644748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Wuchereria bancrofti recombinant antigen for the capture antibody diagnosis of dog heartworm 一种重组班氏乌切利氏菌抗原对犬心丝虫捕获抗体诊断的评价
Darleide Correia, Esdras Gueiros, Wagner J T Santos, A. Rocha, L. Alves
{"title":"Evaluation of a Wuchereria bancrofti recombinant antigen for the capture antibody diagnosis of dog heartworm","authors":"Darleide Correia, Esdras Gueiros, Wagner J T Santos, A. Rocha, L. Alves","doi":"10.35259/isi.2022_52182","DOIUrl":"https://doi.org/10.35259/isi.2022_52182","url":null,"abstract":"and specificity of 73% were determined when compared to SNAP 4Dx. Conclusion: The findings revealed that the W. bancrofti antigen is not ideal for the immunodiagnosis of canine heartworm disease using the indirect ELISA assay. However, it was the first Brazilian ELISA developed to search for antibodies in dogs with heartworm disease. Also, the comparison with the SNAP 4Dx, an antigen-capture assay, is not ideal. Some infected animals do not produce antibodies and false negatives in SNAP4Dx could be infected and produce antibodies. It is possibly the reason for the greater positivity seen for the negative group from the endemic area in comparison with those from a non-endemic locality. Further studies aiming at the development of antibody tests for heartworm disease should be pursued, so as to better define the real status of the canine immune response in endemic and non-endemic areas.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81585079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening system development for HDAC1/Sp1 complex inhibitors HDAC1/Sp1复合物抑制剂筛选系统的开发
F. Verza, Ana Saltoratto, M. Marins
{"title":"Screening system development for HDAC1/Sp1 complex inhibitors","authors":"F. Verza, Ana Saltoratto, M. Marins","doi":"10.35259/isi.2022_52294","DOIUrl":"https://doi.org/10.35259/isi.2022_52294","url":null,"abstract":"gene expression regulators. expression on this to target the elements that interact with Sp1 such as histone deacetylase 1 (HDAC1). The interaction of its domain and the C-terminal region of Sp1 inhibits the connection of HDAC1 with the promoter region of genes and repress gene expression. Objective: Considering the role of post-translational modifications in determining the transcriptional activity of Sp1 and the interaction with other proteins such as HDAC1, we report a system for the development of inhibitors of the HDAC1/Sp1 complex using mammalian two-hybrid system. Methodology: In this strategic approach, the DNA-binding domain and the transcriptional activation domain are produced by separate plasmids and become closely associated when the protein HDAC1 fused to a DNA-binding domain, interacts with the protein Sp1 fused to a transcriptional activation domain. The interaction between the proteins results in transcription of the firefly luciferase reporter gene. Results: With this experimental system we can select substances that inhibit the HDAC1/Sp1 interaction and use them in the development of anticancer drugs based on the activation of tumor suppressor genes regulated by Sp1/HDAC1 complex. Conclusion: Our system is applicable to the screening of HDAC1/Sp1 binding inhibitors to assess their antitumor and toxicity activity, but due to the complexity of histone modifications and transcriptional initiation, we cannot rule out the involvement of other epigenetic enzymes or transcription factors.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89190497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In silico identification of epitopes target of humoral response against Sphingomyelinase 2 (Sph2) of pathogenic Leptospira 致病性钩端螺旋体鞘磷脂酶2 (Sph2)体液应答表位靶点的计算机识别
Laura Ataídes, Fernanda Maia, F. Conte, Rodrigo Silva
{"title":"In silico identification of epitopes target of humoral response against Sphingomyelinase 2 (Sph2) of pathogenic Leptospira","authors":"Laura Ataídes, Fernanda Maia, F. Conte, Rodrigo Silva","doi":"10.35259/isi.2022_52218","DOIUrl":"https://doi.org/10.35259/isi.2022_52218","url":null,"abstract":"1, a similar pattern of peptide 2, where 5% of the non-reactive samples (4) presented antibodies against this peptide. Conclusion: Through immunoinformatics it was possible to identify 2 epitopes in this protein. The ELISA tests allowed the evaluation of the immunogenicity of peptides 1 and 2 against antibodies present in the serum of patients. We believe that this study can contribute to advances in vaccine research against leptospirosis.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91453765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信